This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rödel, F. Articles by Rödel, C. Search for Related Content PubMed PubMed Citation Articles by Rödel, F. Articles by Rödel, C.

Survivin as a Radioresistance Factor, and Prognostic and Therapeutic Target for Radiotherapy in Rectal Cancer

¹ Department of Radiation Oncology, Institutes of ² Clinical Immunology, and ³ Pathology, University of Erlangen-Nuremberg, Erlangen, Germany

Requests for reprints: Franz Rödel, Department of Radiation Therapy, Universitätsstr. 27, 91054 Erlangen, Germany. Phone: 49-9131-853-3405; Fax: 49-9131-853-9335; E-mail: franz.roedel{at}strahlen.med.uni-erlangen.de.

Apoptosis levels have been shown to predict tumor response to preoperative radiochemotherapy in rectal cancer. Recently, the prominent role of survivin, a structurally unique member of the inhibitor of apoptosis protein family, has been shown in colorectal cancer tumorigenesis and prognosis. In this study, we investigated whether survivin plays a direct role in mediating radiation resistance. We used short interfering RNA molecules to decrease survivin in radioresistant SW480 and intermediately radioresistant HCT-15 colorectal cancer cells. This resulted in a significant decrease of survivin mRNA and protein expression with a maximum at 24 to 48 hours after transfection. If irradiated during this sensitive period, an increased percentage of apoptotic cells and an increased caspase 3/7 activity in parallel with a decreased cell viability and a reduced clonogenic survival was shown. These effects were more pronounced in the radioresistant SW480 cell line with a radiation-induced cytotoxicity enhancement factor at 10% and 50% survival of 1.8 to 2.2 for SW480 and 1.5 to 1.7 for HCT-15, respectively. Furthermore, transfection with survivin short interfering RNA increased levels of G₂-M arrest and levels of DNA double-strand breaks in irradiated cells. These observations indicate that cell cycle and DNA repair mechanisms may be associated with apoptosis induction in tumor cells that are otherwise resistant to killing by radiation. In a translational study of 59 patients with rectal cancer treated with a combination of radiotherapy and chemotherapy, increased survivin expression was inversely related to the levels of apoptosis, and was also associated with a significantly higher risk of a local tumor recurrence.

This article has been cited by other articles:

				A. B. Kunnumakkara, P. Diagaradjane, S. Guha, A. Deorukhkar, S. Shentu, B. B. Aggarwal, and S. Krishnan Curcumin Sensitizes Human Colorectal Cancer Xenografts in Nude Mice to {gamma}-Radiation by Targeting Nuclear Factor-{kappa}B-Regulated Gene Products Clin. Cancer Res., April 1, 2008; 14(7): 2128 - 2136. [Abstract] [Full Text] [PDF]

				S.-K. Seo, H.-O. Jin, H.-C. Lee, S.-H. Woo, E.-S. Kim, D.-H. Yoo, S.-J. Lee, S. An, C.-H. Rhee, S.-I. Hong, et al. Combined Effects of Sulindac and Suberoylanilide Hydroxamic Acid on Apoptosis Induction in Human Lung Cancer Cells Mol. Pharmacol., March 1, 2008; 73(3): 1005 - 1012. [Abstract] [Full Text] [PDF]

				P. Lechler, X. Wu, W. Bernhardt, V. Campean, S. Gastiger, T. Hackenbeck, B. Klanke, A. Weidemann, C. Warnecke, K. Amann, et al. The Tumor Gene Survivin Is Highly Expressed in Adult Renal Tubular Cells: Implications for a Pathophysiological Role in the Kidney Am. J. Pathol., November 1, 2007; 171(5): 1483 - 1498. [Abstract] [Full Text] [PDF]

				P. de Heer, E. C. de Bruin, E. Klein-Kranenbarg, R. I.J.M. Aalbers, C. A.M. Marijnen, H. Putter, H. J. de Bont, J. F. Nagelkerke, J. H. J.M. van Krieken, H. W. Verspaget, et al. Caspase-3 Activity Predicts Local Recurrence in Rectal Cancer Clin. Cancer Res., October 1, 2007; 13(19): 5810 - 5815. [Abstract] [Full Text] [PDF]

				M. Pennati, M. Folini, and N. Zaffaroni Targeting survivin in cancer therapy: fulfilled promises and open questions Carcinogenesis, June 1, 2007; 28(6): 1133 - 1139. [Abstract] [Full Text] [PDF]

				M. S. Chen, W. A. Woodward, F. Behbod, S. Peddibhotla, M. P. Alfaro, T. A. Buchholz, and J. M. Rosen Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line J. Cell Sci., February 1, 2007; 120(3): 468 - 477. [Abstract] [Full Text] [PDF]

				S. K. Knauer, O. H. Kramer, T. Knosel, K. Engels, F. Rodel, A. F. Kovacs, W. Dietmaier, L. Klein-Hitpass, N. Habtemichael, A. Schweitzer, et al. Nuclear export is essential for the tumor-promoting activity of survivin FASEB J, January 1, 2007; 21(1): 207 - 216. [Abstract] [Full Text] [PDF]

				N. Zhu, L. Gu, H. W. Findley, C. Chen, J.-T. Dong, L. Yang, and M. Zhou KLF5 Interacts with p53 in Regulating Survivin Expression in Acute Lymphoblastic Leukemia J. Biol. Chem., May 26, 2006; 281(21): 14711 - 14718. [Abstract] [Full Text] [PDF]

				E. Tirro, M. L. Consoli, M. Massimino, L. Manzella, F. Frasca, L. Sciacca, L. Vicari, G. Stassi, L. Messina, A. Messina, et al. Altered Expression of c-IAP1, Survivin, and Smac Contributes to Chemotherapy Resistance in Thyroid Cancer Cells. Cancer Res., April 15, 2006; 66(8): 4263 - 4272. [Abstract] [Full Text] [PDF]

				J. Lotem, D. Netanely, E. Domany, and L. Sachs Human cancers overexpress genes that are specific to a variety of normal human tissues PNAS, December 20, 2005; 102(51): 18556 - 18561. [Abstract] [Full Text] [PDF]

				C. Rodel, P. Martus, T. Papadoupolos, L. Fuzesi, M. Klimpfinger, R. Fietkau, T. Liersch, W. Hohenberger, R. Raab, R. Sauer, et al. Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer J. Clin. Oncol., December 1, 2005; 23(34): 8688 - 8696. [Abstract] [Full Text] [PDF]